ArticleBMC chemistry2025
Green and sustainable LC-APCI-MS/MS method for simultaneous quantification of genotoxic nitrosamines in antidiabetic medication: sitagliptin.
Article in BMC chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- A Box-Behnken design-assisted RP-HPLC method development and optimization for simultaneous determination of four antiviral drugs in pharmaceutical dosage forms.Scientific reports · 2026Article
- Sustainability in Analytical Chemistry Illustrated by Pharmaceutical Nitrosamine Testing.Electrophoresis · 2026Review
- Review
- Correction: Green and sustainable LC‑APCI‑MS/MS method for simultaneous quantification of genotoxic nitrosamines in antidiabetic medication: sitagliptin.BMC chemistry · 2025Article
Corrections and comments
- Erratum issued
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The International Agency for Research on Cancer categorized nitrosamines as potential or probable human carcinogens. Hence, nitrosamine impurities should be controlled to minimize the cancer risk. Sustainable Development Goal 9 (SDG9: Industry, Innovation, and Infrastructure), Target 9.4 was realized by developing a simple and straightforward LC-APCI-MS/MS method for simultaneous determination of potential nitrosamines: N-nitroso dimethylamine, N-nitroso di isopropyl amine, N-nitroso isopropyl ethylamine and N-nitroso methyl aminopyridine (NDMA, NDIPA, NIPEA and NMAP) in Sitagliptin Phosphate Monohydrate API (STG-API), an antidiabetic medication for type-2 diabetes and validated as per ICH (Q2 R2) guidelines. As a part of SDG9 (Industry, Innovation, and Infrastructure), Target 9.4, greater adoption of clean and environmentally sound technologies is possible by using the current analytical method in view of (a) less consumption of solvents as it has a lower run time of 18 min (b) at-line sample collection (c) simple sample preparation (d) sample preparation process that does not require derivatization or sample extraction. The optimized LC method conditions are an Agilent Poroshell EC C18 column, a flow rate of 0.6 mL/min, an injection volume of 40 µL, a column oven temperature set at 50 °C, and a sample cooler temperature set at 6 °C. A gradient method was adopted using a mixture of mobile phases (Solvent A: 0.1% formic acid in water and Solvent B: a mixture of 50% Methanol and 50% Acetonitrile). The response was obtained with Multiple Reaction Monitoring (MRM) in APCI mode. The current method can quantify NDMA, NIPEA, NDIPA, and NMAP to a lower level of 74.19 ng/g, 19.62 ng/g, 20.36 ng/g, and 13.65 ng/g, respectively, which is less than 10% of the specified limits. Good linearity in the range of Limit of Quantitation (LOQ) to 150% of the specification limit was observed, with correlation coefficients higher than 0.996. The recoveries were over the range between 90.23 and 103.36%. Assessed the method's eco-friendliness by greenness tools like the Modified Green Analytical Procedure Index (MoGAPI), ComplexMoGAPI, Analytical GREEnness (AGREE), and Analytical Eco-Scale, and found it to be eco-friendly.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.